Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Intervalo de año de publicación
1.
Biochim Biophys Acta ; 1860(12): 2869-79, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27451957

RESUMEN

The paper proposes a pathophysiologic framework to explain the well-established epidemiological association between exposure to ambient air particle pollution and premature cardiovascular mortality, and offers insights into public health solutions that extend beyond regulatory environmental protections to actions that can be taken by individuals, public health officials, healthcare professionals, city and regional planners, local and state governmental officials and all those who possess the capacity to improve cardiovascular health within the population. The foundation of the framework rests on the contribution of traditional cardiovascular risk factors acting alone and in concert with long-term exposures to air pollutants to create a conditional susceptibility for clinical vascular events, such as myocardial ischemia and infarction; stroke and lethal ventricular arrhythmias. The conceptual framework focuses on the fact that short-term exposures to ambient air particulate matter (PM) are associated with vascular thrombosis (acute coronary syndrome, stroke, deep venous thrombosis, and pulmonary embolism) and electrical dysfunction (ventricular arrhythmia); and that individuals having prevalent heart disease are at greatest risk. Moreover, exposure is concomitant with changes in autonomic nervous system balance, systemic inflammation, and prothrombotic/anti-thrombotic and profibrinolytic-antifibrinolytic balance. Thus, a comprehensive solution to the problem of premature mortality triggered by air pollutant exposure will require compliance with regulations to control ambient air particle pollution levels, minimize exposures to air pollutants, as well as a concerted effort to decrease the number of people at-risk for serious clinical cardiovascular events triggered by air pollutant exposure by improving the overall state of cardiovascular health in the population. This article is part of a Special Issue entitled Air Pollution, edited by Wenjun Ding, Andrew J. Ghio and Weidong Wu.


Asunto(s)
Contaminación del Aire/efectos adversos , Arritmias Cardíacas/etiología , Muerte Súbita Cardíaca/etiología , Isquemia Miocárdica/etiología , Material Particulado/toxicidad , Trombosis/etiología , Arritmias Cardíacas/metabolismo , Arritmias Cardíacas/patología , Muerte Súbita Cardíaca/patología , Susceptibilidad a Enfermedades , Células Espumosas/efectos de los fármacos , Células Espumosas/metabolismo , Células Espumosas/patología , Humanos , Inflamación , Lipoproteínas LDL/agonistas , Lipoproteínas LDL/biosíntesis , Isquemia Miocárdica/metabolismo , Isquemia Miocárdica/patología , Estrés Oxidativo , Salud Pública , Especies Reactivas de Oxígeno/agonistas , Especies Reactivas de Oxígeno/metabolismo , Factores de Riesgo , Trombosis/metabolismo , Trombosis/patología
2.
Biochim Biophys Acta ; 1860(12): 2863-8, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27156486

RESUMEN

BACKGROUND: Atherosclerosis is a progressive disease characterized by the accumulation of lipids and fibrous plaque in the arteries. Its etiology is very complicated and its risk factors primarily include genetic defects, smoking, hyperlipidemia, hypertension, lack of exercise, and infection. Recent studies suggest that fine particulate matter (PM2.5) air pollution may also contribute to the development of atherosclerosis. SCOPE OF REVIEW: The present review integrates current experimental evidence with mechanistic pathways whereby PM2.5 exposure can promote the development of atherosclerosis. MAJOR CONCLUSIONS: PM2.5-mediated enhancement of atherosclerosis is likely due to its pro-oxidant and pro-inflammatory effects, involving multiple organs, different cell types, and various molecular mediators. GENERAL SIGNIFICANCE: Studies about the effects of PM2.5inhalation on atherosclerosis may yield a better understanding of the link between air pollution and major cardiovascular diseases, and provide useful information for policy makers to determine acceptable levels of PM2.5 air quality. This article is part of a Special Issue entitled Air Pollution, edited by Wenjun Ding, Andrew J. Ghio and Weidong Wu.


Asunto(s)
Contaminación del Aire/efectos adversos , Aterosclerosis/etiología , Exposición por Inhalación/efectos adversos , Material Particulado/toxicidad , Placa Aterosclerótica/etiología , Especies Reactivas de Oxígeno/agonistas , Aterosclerosis/metabolismo , Aterosclerosis/patología , Células Espumosas/efectos de los fármacos , Células Espumosas/metabolismo , Células Espumosas/patología , Humanos , Hiperlipidemias/fisiopatología , Hipertensión/fisiopatología , Lipoproteínas LDL/agonistas , Lipoproteínas LDL/biosíntesis , Estrés Oxidativo , Tamaño de la Partícula , Placa Aterosclerótica/metabolismo , Placa Aterosclerótica/patología , Especies Reactivas de Oxígeno/metabolismo , Factores de Riesgo , Conducta Sedentaria , Fumar/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...